FilingSEC EDGARPOS AM
Scinai Immunotherapeutics files post-effective amendment for ATM offering.
· SEC accepted
StageOngoing
Filing content
Scinai Immunotherapeutics filed a post-effective amendment for its ATM offering while remaining in non-compliance with Nasdaq's minimum bid price requirement.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…